Skip to content

13F-HR filed by Trustees of Columbia University in the City of New York

Trustees of Columbia University in the City of New York filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 13 holding rows worth $47,385,633.

Accession
0000904454-24-000136
Filed
2024-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 13 entries on the cover page, a total value of $47,385,633 stated on the cover page (in dollars after the unit check, H1), rows summing to $47,385,633 with VALUE read as dollars as filed, 13F file number 028-20933. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BERKSHIRE HATHAWAY INC DEL084670108CL A76$41,239,502dollars as filed
RAPT THERAPEUTICS INC75382E109COM73,383$1,823,568dollars as filed
TENAYA THERAPEUTICS INC87990A106COM291,828$945,522dollars as filed
KANZHUN LIMITED48553T106SPONSORED ADS54,722$908,932dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM192,973$652,249dollars as filed
SURROZEN INC86889P208COMMON STOCK47,930$450,542dollars as filed
Berkshire Hathaway Inc084670702COM1,100$392,326dollars as filed
QUANTUMSCAPE CORP COM CL A74767V109Stock48,464$336,825dollars as filed
VOR BIOPHARMA INC929033108COM91,910$206,798dollars as filed
AMPLITUDE INC COM CL A03213A104Stock12,410$157,855dollars as filed
Xilio Therapeutics Inc.98422T100COM249,635$137,299dollars as filed
PULMONX CORP745848101COM10,477$133,582dollars as filed
SURROZEN INC86889P117*W EXP 08/01/20333,333$633dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-24-000136this filing2024-02-13acceptance time not in the bulk data set